Prulifloxacin: NAD-441A, NM 441, Quisnon

Author：

ISSN： 1174-5886

Source： Drugs in R&D, Vol.3, Iss.6, 2002-01, pp. : 426-430

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prulifloxacin

By Susan J. Keam Caroline M. Perry

Drugs, Vol. 64, Iss. 19, 2004-01 ,pp. : 2221-2234

Adis International

Access to resources Recommend Favorite

The curcuminoid CLEFMA selectively induces cell death in H441 lung adenocarcinoma cells via oxidative stress

By Sahoo Kaustuv

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 558-567

Springer Publishing Company

Access to resources Recommend Favorite

Automation and Validation of Information in Pharmaceutical ProcessingJoseph F. de Spautz (Editor), Drugs and the Pharmaceutical Sciences, Marcel Dekker; New York; Vol. 90, 1998, pp. 441; ISBN 0-8247-0119-4

By Zimmermann I.

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 51, Iss. 1, 2001-01 ,pp. : 86-86

Elsevier

Access to resources Recommend Favorite

Prulifloxacin ECG Study

By > Dionisio Paolo

Clinical Drug Investigation, Vol. 30, Iss. 4, 2010-04 ,pp. : 275-277

Adis International

Access to resources Recommend Favorite

Prulifloxacin: A Viewpoint by Pietro E. Varaldo

By Pietro E. Varaldo

Drugs, Vol. 64, Iss. 19, 2004-01 ,pp. : 2235-2236

Adis International

Access to resources Recommend Favorite